These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 17600820)

  • 1. Physiogenomic association of statin-related myalgia to serotonin receptors.
    Ruaño G; Thompson PD; Windemuth A; Seip RL; Dande A; Sorokin A; Kocherla M; Smith A; Holford TR; Wu AH
    Muscle Nerve; 2007 Sep; 36(3):329-35. PubMed ID: 17600820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin therapy induces ultrastructural damage in skeletal muscle in patients without myalgia.
    Draeger A; Monastyrskaya K; Mohaupt M; Hoppeler H; Savolainen H; Allemann C; Babiychuk EB
    J Pathol; 2006 Sep; 210(1):94-102. PubMed ID: 16799920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle symptoms associated with statins: a series of twenty patients.
    Soininen K; Niemi M; Kilkki E; Strandberg T; Kivistö KT
    Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):51-4. PubMed ID: 16433891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-of-1 (single-patient) trials for statin-related myalgia.
    Joy TR; Monjed A; Zou GY; Hegele RA; McDonald CG; Mahon JL
    Ann Intern Med; 2014 Mar; 160(5):301-10. PubMed ID: 24737272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proximal myopathy secondary to statin treatment in a patient with Hashimoto thyroiditis].
    Ferreiro JL; Dapena Mdel C; Suárez RL; Pérez-Argüelles BS; Vázquez CM
    Endocrinol Nutr; 2009; 56(7):387. PubMed ID: 19883901
    [No Abstract]   [Full Text] [Related]  

  • 7. CYP2D6*4 polymorphism is associated with statin-induced muscle effects.
    Frudakis TN; Thomas MJ; Ginjupalli SN; Handelin B; Gabriel R; Gomez HJ
    Pharmacogenet Genomics; 2007 Sep; 17(9):695-707. PubMed ID: 17700359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
    Roeters van Lennep HW; Liem AH; Dunselman PH; Dallinga-Thie GM; Zwinderman AH; Jukema JW
    Curr Med Res Opin; 2008 Mar; 24(3):685-94. PubMed ID: 18226326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genetic determinants of atorvastatin response.
    Rodrigues AC; Hirata MH; Hirata RD
    Curr Opin Mol Ther; 2007 Dec; 9(6):545-53. PubMed ID: 18041665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased skeletal muscle mitochondrial DNA in patients treated with high-dose simvastatin.
    Schick BA; Laaksonen R; Frohlich JJ; Päivä H; Lehtimäki T; Humphries KH; Côté HC
    Clin Pharmacol Ther; 2007 May; 81(5):650-3. PubMed ID: 17329991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The C3435T polymorphism in ABCB1 influences atorvastatin efficacy and muscle symptoms in a high-risk vascular cohort.
    Hoenig MR; Walker PJ; Gurnsey C; Beadle K; Johnson L
    J Clin Lipidol; 2011; 5(2):91-6. PubMed ID: 21392722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of coenzyme Q(10) supplementation on simvastatin-induced myalgia.
    Young JM; Florkowski CM; Molyneux SL; McEwan RG; Frampton CM; George PM; Scott RS
    Am J Cardiol; 2007 Nov; 100(9):1400-3. PubMed ID: 17950797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins: much more than just a lipid-lowering therapy.
    Raja SG; Dreyfus GD
    Indian Heart J; 2004; 56(3):204-9. PubMed ID: 15584561
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin.
    Brunham LR; Lansberg PJ; Zhang L; Miao F; Carter C; Hovingh GK; Visscher H; Jukema JW; Stalenhoef AF; Ross CJ; Carleton BC; Kastelein JJ; Hayden MR
    Pharmacogenomics J; 2012 Jun; 12(3):233-7. PubMed ID: 21243006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should high creatine kinase discourage the initiation or continuance of statins for the treatment of hypercholesterolemia?
    Glueck CJ; Rawal B; Khan NA; Yeramaneni S; Goldenberg N; Wang P
    Metabolism; 2009 Feb; 58(2):233-8. PubMed ID: 19154957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SLCO1B1 polymorphism is not associated with risk of statin-induced myalgia/myopathy in a Czech population.
    Hubáček JA; Dlouhá D; Adámková V; Zlatohlavek L; Viklický O; Hrubá P; Češka R; Vrablík M
    Med Sci Monit; 2015 May; 21():1454-9. PubMed ID: 25992810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SLCO1B1*5 genetic variant is associated with statin-induced side effects.
    Voora D; Shah SH; Spasojevic I; Ali S; Reed CR; Salisbury BA; Ginsburg GS
    J Am Coll Cardiol; 2009 Oct; 54(17):1609-16. PubMed ID: 19833260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of benefits and risks of rosuvastatin versus atorvastatin from a meta-analysis of head-to-head randomized controlled trials.
    Wlodarczyk J; Sullivan D; Smith M
    Am J Cardiol; 2008 Dec; 102(12):1654-62. PubMed ID: 19064019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of low-density lipoprotein cholesterol reduction after switching patients on other statins to rosuvastatin or simvastatin in a real-world clinical practice setting.
    Fox KM; Gandhi SK; Ohsfeldt RL; Davidson MH
    Am J Manag Care; 2007 Dec; 13 Suppl 10():S270-5. PubMed ID: 18095777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of efficacy and safety of atorvastatin (80 mg) to simvastatin (20 to 40 mg) in patients aged <65 versus >or=65 years with coronary heart disease (from the Incremental DEcrease through Aggressive Lipid Lowering [IDEAL] study).
    Tikkanen MJ; Holme I; Cater NB; Szarek M; Faergeman O; Kastelein JJ; Olsson AG; Larsen ML; Lindahl C; Pedersen TR;
    Am J Cardiol; 2009 Mar; 103(5):577-82. PubMed ID: 19231315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.